News items 2015
-
New guidelines on good distribution practice for APIs
| 31 March 2015 |
The European Commission has published new guidelines on good distribution practice (GDP) for active substances (API) for medicinal products for human use.
-
New management at the DHMA
| 16 March 2015 |
As from 13 March 2015, Jakob Cold has been appointed Acting Director General of the Danish Health and Medicines Authority. Anne-Marie Vangsted will continue as Director with special responsibility for the DHMA's supervision.
-
Danish Pharmacovigilance Update, February 2015
| 16 March 2015 |
The February issue of Danish Pharmacovigilance Update with news from the EU, the DHMA and short news.
-
Else Smith to resign as Director General of the DHMA
| 16 March 2015 |
We confirm that as from 12 March 2015 Else Smith is no longer Director General of the Danish Health and Medicines Authority.
-
Requirements for companies distributing and handling euphoriant substances
| 11 March 2015 |
We have gathered information about the requirements for authorisations, storage, accounting and reporting of euphoriant substances.
-
Warning against Slimex 15 and Slimex 15 New Formula
| 09 March 2015 |
The Danish Health and Medicines Authority warns against taking the weight-loss products "Slimex 15" and "Slimex 15 New Formula" that are sold on the internet. The weight-loss products contain sibutramine that may cause serious side effects.
-
Wholesale Distribution Authorisations and GDP certificates can now be transferred to EudraGMDP
| 09 March 2015 |
We can now transfer Wholesale Distribution Authorisations and Good Distribution Practice certificates to EudraGMDP, a Community database in the EU.
-
The MMR vaccine is a safe vaccine
| 04 March 2015 |
We have reviewed the reported adverse reactions from the MMR vaccine during the past five years.